Last August, the US Food and Drug Administration approved the drug zidovudine (AZT) for treating HIV - positive women during pregnancy. (newscientist.com)
Steve Schnittman of the NIH told a research meeting in Albuquerque that because there are now several drugs to treat HIV, studies of zidovudine alone are «not relevant in 1993». (newscientist.com)
These children typically receive zidovudine for four to six weeks after birth. (health.com)